TetraGenetics, an AbCellera company, empowers antibody discovery against difficult-to-drug targets by providing high quality recombinant transmembrane proteins, including human ion channels, G protein-coupled receptors and other transmembrane proteins.
Transmembrane proteins, which are implicated in many human diseases, are both difficult to produce and difficult to drug. TetraGenetics’ protein production platform, TetraExpress™, uses the protist Tetrahymena thermophila to quickly produce large quantities of properly folded, functional transmembrane proteins. This solves the protein production challenge, providing the critical reagents needed throughout the antibody discovery process, from immunization and screening to characterization and protein engineering.
Location: United States, Massachusetts, Arlington
Member count: 11-50
Total raised: $1.54M
Founded date: 2004
Investors 4
| Date | Name | Website |
| - | Bantam Gro... | bantamgrou... |
| - | Excell Par... | excellny.c... |
| - | T1D Fund | t1dfund.or... |
| - | Launchpad ... | launchpadv... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 14.01.2016 | Grant | $1.54M | - | finsmes.co... |
Mentions in press and media 3
| Date | Title | Description | Category | Author | Source |
| 02.05.2017 | TetraGenet... | TetraGenetics, a biopharmaceut... | - | - | citybizlis... |
| 02.05.2017 | Term Sheet... | PUTTING THE SILICON IN SILICON... | - | - | fortune.co... |
| 14.01.2016 | Tetragenet... | Tetragenetics Inc., an Arlingt... | USA | - | finsmes.co... |